Choreo LLC’s Bio-Techne TECH Stock Holding History

Choreo LLC’s Portfolio TECH Stock Details TECH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$258K	Sell	4,941 -1,770	-26%	-$106K	﹤0.01%	1342
2025 Q4	$397K	Sell	6,711 -732	-10%	-$44.5K	0.01%	1040
2025 Q3	$414K	Buy	7,443 +2,083	+39%	+$112K	0.01%	1029
2025 Q2	$276K	Buy	+5,360	New	+$269K	﹤0.01%	1232
2025 Q1	–	Sell	-4,812	Closed	-$348K	–	1595
2024 Q4	$348K	Buy	4,812 +603	+14%	+$44.3K	0.01%	1101
2024 Q3	$329K	Sell	4,209 -102	-2%	-$7.67K	﹤0.01%	1152
2024 Q2	$309K	Buy	+4,311	New	+$317K	0.01%	1085
2022 Q2	–	Sell	-20,000	Closed	-$2.17M	–	243
2022 Q1	$2.17M	Buy	+20,000	New	+$2.06M	0.11%	58

Other funds holding TECH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Choreo LLC's TECH Position: Q1 2026 in Review

Choreo LLC reduced its Bio-Techne (TECH) stake by 26% in Q1 2026, selling an estimated $106K and leaving 4,941 shares worth $258K. The position accounts for ﹤0.01% of the portfolio, ranked #1342.

Choreo LLC first reported a position in TECH in Q1 2022 and has held it in 8 quarters since. The position peaked at $2.17M in Q1 2022. 582 funds tracked by Wall St. Rank hold TECH as of Q1 2026.

Choreo LLC held 4,941 shares of Bio-Techne worth $258K as of Q1 2026.
Choreo LLC sold 1,770 Bio-Techne shares in Q1 2026, an estimated $106K.
Bio-Techne made up ﹤0.01% of Choreo LLC's portfolio in Q1 2026, its #1342 holding.
Choreo LLC first reported a position in Bio-Techne in Q1 2022 and has held it in 8 quarters since.
Choreo LLC's Bio-Techne position peaked at $2.17M in Q1 2022.
582 funds tracked by Wall St. Rank held Bio-Techne as of Q1 2026.

Based on Choreo LLC's 13F filing for Q1 2026, filed 13 May 2026.